Redcliffe Labs founder discusses new era of diagnostics in India

D.JainD.Jain
BulletArticle
RED 2022 C-Suite Perspectives
Share this:
Copy link
Redcliffe Labs founder discusses new era of diagnostics in India_thumbnail

Since its inception in 2018, Redcliffe Labs has endeavoured to be a disrupter in India’s lab diagnostics ecosystem. In this talk at RED 2022, founder and managing director Dheeraj Jain discusses some of the company’s key strategic initiatives, such as the use of temperature controlled transport bags and an AI/ML supported infrastructure with a complete ‘Glucose to Genetics’ approach.

Share this:
Copy link

More on same topic

Virtual reference site visit: Changi General Hospital Singapore

How 5G enables telemedicine: Taiwan’s success story

Recommended topics

SequencingRED 2020Rare Diseases
Next Read
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
3 steps to mitigate the impact of interference
  • Clinician Engagement, Coagulation, Disease Area, Management
3 steps to mitigate the impact of interference
A guide to balancing quality, speed and cost
  • Operational Excellence, Operations
A guide to balancing quality, speed and cost
Scroll to Top